Should you buy Abbott Laboratories (ABL)?

Miksic covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Edwards Lifesciences, and Tandem Diabetes Care. Currently, the analyst consensus on Abbott Laboratories is a Strong Buy with an average price target of $127.75, implying a 22.6% upside from current levels.

What does Abbott Laboratories do?

Stay up to date on Abbott Laboratories analyst ratings. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs.

What products does Abbott sell?

Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.